Acadia Pharmaceuticals
ACAD
ACAD
247 hedge funds and large institutions have $3.25B invested in Acadia Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 93 increasing their positions, 73 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
247
Holders Change
+12
Holders Change %
+5.11%
% of All Funds
3.94%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.11%
New
40
Increased
93
Reduced
73
Closed
27
Calls
$33.5M
Puts
$56.7M
Net Calls
-$23.2M
Net Calls Change
-$30M
Top Buyers
| 1 |
Millennium Management
New York
|
+$40.1M |
| 2 |
RI
RTW Investments
New York
|
+$37.4M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$19.1M |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$18.3M |
| 5 |
FAM
Fred Alger Management
New York
|
+$18.1M |
Top Sellers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$85.1M |
| 2 |
Morgan Stanley
New York
|
-$39M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$27.7M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$19.9M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$18.2M |
